US FDA approves Astellas drug for leaky bladder
WASHINGTON, June 28
WASHINGTON, June 28 (Reuters) - U.S. drugs regulators gave the nod to Astellas Pharma Inc's pill for overactive bladder on Thursday, boosting the Japanese drugmaker's foothold in the market for the condition.
The Food and Drug Administration approved the once-daily pill, mirabegron, for adults who cannot control their bladder muscles, following a positive recommendation from FDA advisers.
Trending On Reuters
We are living longer but not creating financial plans to keep pace. Advisers give tips on how to make sure you don’t outlive your money. Video